Total Payments
$636.02
2024 Payments
$331.17
Companies
8
Transactions
32
Medicare Patients
1,817
Medicare Billing
$151,318
Payment Breakdown by Category
Food & Beverage$636.02 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $636.02 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $174.78 | 9 | $0 (2024) |
| ABBVIE INC. | $163.91 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $97.47 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $78.09 | 4 | $0 (2024) |
| PFIZER INC. | $53.10 | 3 | $0 (2024) |
| SANOFI PASTEUR INC. | $34.96 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $18.65 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $15.06 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $331.17 | 17 | ABBVIE INC. ($119.74) |
| 2023 | $226.27 | 11 | Novo Nordisk Inc ($70.78) |
| 2022 | $78.58 | 4 | GlaxoSmithKline, LLC. ($28.87) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Obesity | ||||||
| 08/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Biological | ||||||
| 07/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: VACCINES | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Obesity | ||||||
| 03/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Obesity | ||||||
| 11/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: Cardiovascular | ||||||
| 08/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Obesity | ||||||
| 07/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: Cardiovascular | ||||||
| 05/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 460 | 747 | $83,548 | $39,062 |
| 2022 | 14 | 443 | 759 | $80,637 | $35,833 |
| 2021 | 10 | 454 | 743 | $87,573 | $42,024 |
| 2020 | 13 | 460 | 794 | $90,950 | $34,398 |
Total Patients
1,817
Total Services
3,043
Medicare Billing
$151,318
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 244 | $36,112 | $15,918 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $13,969 | $6,501 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 105 | $11,130 | $4,544 | 40.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,046 | $3,395 | 67.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 28 | $5,964 | $2,915 | 48.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 29 | 29 | $3,528 | $2,123 | 60.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $1,056 | $940.48 | 89.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $1,890 | $808.92 | 42.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 84 | $1,596 | $799.68 | 50.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $429.00 | $382.07 | 89.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 12 | 12 | $1,152 | $317.46 | 27.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $684.00 | $284.62 | 41.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 20 | 38 | $912.00 | $98.28 | 10.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 16 | $80.00 | $35.20 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 232 | $34,336 | $14,985 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $13,282 | $6,279 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 135 | $14,310 | $6,091 | 42.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 30 | $6,390 | $2,671 | 41.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 27 | $2,700 | $1,897 | 70.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 40 | 94 | $1,786 | $901.72 | 50.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 32 | $1,056 | $891.70 | 84.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 16 | 19 | $1,669 | $555.05 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 54 | $2,160 | $432.78 | 20.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $495.00 | $421.75 | 85.2% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 14 | 15 | $1,440 | $409.22 | 28.4% |
About Ryan Knape
Ryan Knape is a Physician Assistant healthcare provider based in Adrian, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2012. The National Provider Identifier (NPI) number assigned to this provider is 1841535762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Knape has received a total of $636.02 in payments from pharmaceutical and medical device companies, with $331.17 received in 2024. These payments were reported across 32 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($636.02).
As a Medicare-enrolled provider, Knape has provided services to 1,817 Medicare beneficiaries, totaling 3,043 services with total Medicare billing of $151,318. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Adrian, MI
- Active Since 12/04/2012
- Last Updated 11/03/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1841535762
Products in Payments
- VRAYLAR (Drug) $103.87
- Wegovy (Drug) $94.20
- ELIQUIS (Drug) $78.09
- TRELEGY ELLIPTA (Drug) $68.60
- PREVNAR 20 (Biological) $53.10
- Rybelsus (Drug) $38.87
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $34.96
- VIBERZI (Drug) $29.95
- SHINGRIX (Biological) $28.87
- Ozempic (Drug) $21.27
- Saxenda (Drug) $20.44
- REXULTI (Drug) $18.65
- UBRELVY (Drug) $15.87
- Veozah (Drug) $15.06
- QULIPTA (Drug) $14.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Adrian
Taylor Hennrick, Pa-C, PA-C
Physician Assistant — Payments: $363,108
Physician Assistant $363,108
Salah Mansour, Pa-C, PA-C
Physician Assistant — Payments: $10,782
Physician Assistant $10,782
Gabrielle Groff, Pa-C, PA-C
Physician Assistant — Payments: $3,659
Physician Assistant $3,659
George Gardner, Pa-C, PA-C
Physician Assistant — Payments: $1,716
Physician Assistant $1,716
Mrs. Kelci Hensley, Pa-C, PA-C
Physician Assistant — Payments: $1,687
Physician Assistant $1,687
Mrs. Alisha Hall, Pa-C, PA-C
Physician Assistant — Payments: $1,123
Physician Assistant $1,123